Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IOP Lowering in Progressive High Myopia
NCT05850936Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2023
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of timolol in high myopia (HM) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Annualized change in axial length at 12 months. Started Jun 2023; status: active, not recruiting.
02
Drugs
timolol
03
Conditions
high myopia (HM)
Beyond the preview
Go deeper on NCT05850936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05850936.